Haemonetics Corporation
Income Statement
| Line Item | FY2010 | FY2009 |
|---|---|---|
| Revenue | $645.4M | $597.9M |
| Cost of Revenue | $307.9M | $289.7M |
| Gross Profit | $337.5M | $308.2M |
| Gross Margin | 52.3% | 51.5% |
| Operating Expenses | ||
| Research & Development | $26.4M | $23.9M |
| SG&A Expense | $214.5M | $198.7M |
| Operating Income | $83.3M | $85.6M |
| Operating Margin | 12.9% | 14.3% |
| Interest Expense | $742.0K | $64.0K |
| Pretax Income | $81.3M | $85.0M |
| Income Tax Expense | $22.9M | $25.7M |
| Net Income | $58.4M | $59.3M |
| Net Margin | 9.0% | 9.9% |
| EPS (Basic) | $2.29 | $2.34 |
| EPS (Diluted) | $2.24 | $2.27 |
| Shares Outstanding (Basic) | 25.5M | 25.4M |
| Shares Outstanding (Diluted) | 26.1M | 26.2M |
| Dividends Per Share | — | — |